
DrugParadigm provides ready-to-use AI models to speed up drug discovery for researchers. It hosts curated models that run from SMILES, sequences, or structures with no GPUs or complex setup. It is a B2B AI software platform offering scalable access and workflow integrations for biotech startups, research labs, and students. The platform supports production-grade tasks such as docking, ADMET, and knockdown prediction. It targets the drug discovery market to accelerate experimentation and smarter therapeutics.

DrugParadigm provides ready-to-use AI models to speed up drug discovery for researchers. It hosts curated models that run from SMILES, sequences, or structures with no GPUs or complex setup. It is a B2B AI software platform offering scalable access and workflow integrations for biotech startups, research labs, and students. The platform supports production-grade tasks such as docking, ADMET, and knockdown prediction. It targets the drug discovery market to accelerate experimentation and smarter therapeutics.